Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 510.00 | 580.00 | 0.8793 | 0.7791 | |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1127.00 | 1357.25 | 0.8304 | 0.6951 | |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1297.00 | 1357.25 | 0.9556 | 0.9208 | |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1418.00 | 1357.25 | 1.0448 | 1.0795 | |
BT-20 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 1402.00 | 1357.25 | 1.0330 | 1.0586 |
BT-20 | 17-AAG | 0.001 | uM | 8 | 1250.00 | 622.75 | 1656.00 | 1357.25 | 1.2201 | 1.3873 |
BT-20 | 17-AAG | 0.000066069 | uM | 8 | 1250.00 | 622.75 | 2111.00 | 1357.25 | 1.5554 | 1.9628 |
BT-20 | Linsitinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1738.00 | 1357.25 | 1.2805 | 1.4922 |
BT-20 | Erlotinib | 19.9526 | uM | 8 | 1250.00 | 622.75 | 1222.00 | 1357.25 | 0.9004 | 0.8217 |
BT-20 | Lapatinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1881.00 | 1357.25 | 1.3859 | 1.6738 |
BT-20 | Lapatinib | 0.0016596 | uM | 8 | 1250.00 | 622.75 | 2123.00 | 1357.25 | 1.5642 | 1.9778 |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 2048.00 | 1357.25 | 1.5089 | 1.8840 | |
BT-20 | 17-AAG | 0.1 | uM | 8 | 1250.00 | 622.75 | 525.00 | 1357.25 | 0.3868 | -0.1409 |
BT-20 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1944.00 | 1357.25 | 1.4323 | 1.7533 |
BT-20 | Lapatinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 1855.00 | 1357.25 | 1.3667 | 1.6409 |
BT-20 | Linsitinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 1675.00 | 1357.25 | 1.2341 | 1.4116 |
BT-20 | Lapatinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 1651.00 | 1357.25 | 1.2164 | 1.3809 |
BT-20 | Linsitinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1800.00 | 1357.25 | 1.3262 | 1.5711 |
BT-20 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1694.00 | 1357.25 | 1.2481 | 1.4359 |
BT-20 | Erlotinib | 1 | uM | 8 | 1250.00 | 622.75 | 1776.00 | 1357.25 | 1.3085 | 1.5406 |
BT-20 | 17-AAG | 0.000302 | uM | 8 | 1250.00 | 622.75 | 1428.00 | 1357.25 | 1.0521 | 1.0925 |
BT-20 | Lapatinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1364.00 | 1357.25 | 1.0050 | 1.0088 |
BT-20 | 17-AAG | 0.31623 | uM | 8 | 1250.00 | 622.75 | 406.00 | 1357.25 | 0.2991 | -0.3166 |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1210.00 | 1357.25 | 0.8915 | 0.8057 | |
BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1045.00 | 1357.25 | 0.7699 | 0.5849 |